Will CLF report Q1 2026 adjusted EBITDA above $200M?
Current Prediction
Why This Question Matters
Q1 2026 EBITDA is the make-or-break data point for the entire CLF thesis. The slab contract expiration should add ~$500M annualized EBITDA, making Q1 the first quarter reflecting this benefit. If EBITDA exceeds $200M (from $37M full-year FY2025), it validates the inflection thesis and de-escalates STRAINED funding fragility. Below $100M would suggest the commodity headwinds overwhelm the slab contract benefit.
Prediction Distribution
Individual Predictions(9 runs)
The slab contract expiration is real and the $500M annualized benefit is plausible — 1.5M tons redirected from loss-making slab sales to higher-margin products. Q1 2026 ASP is up $60/ton vs Q4 with costs up only $20/ton, implying ~$40/ton net margin improvement across ~4.1M tons (~$164M improvement from pricing alone). However, FY2025 showed $37M total EBITDA, and Q4 2025 was -$21M. To reach $200M in Q1 requires not just slab contract benefit but also favorable HRC pricing and volume execution. The 50:1 operating leverage means this is plausible if pricing cooperates, but the threshold is ambitious for the first transition quarter. Management's bullish guidance is discounted by the CEO's $37M stock sale two days after earnings.
The math is demanding. FY2025 had $37M EBITDA on 16.2M tons and $1,005 ASP. $200M in Q1 requires approximately $50/ton EBITDA on ~4M tons. In FY2024, CLF produced $773M on 15.6M tons (~$50/ton). So $200M Q1 requires return to FY2024-level unit economics in a single quarter. The slab contract benefit is real but Q1 is a transition quarter — the benefit phases in as new production mix ramps. Auto production volumes (28% of revenue) remain uncertain for Q1. The pricing structure (35-40% fixed annual, 25% CRU month lag) means HRC pricing improvements flow through with a lag. More likely Q1 lands in the $100-180M range as transition effects dampen the full benefit.
The $500M annualized slab benefit implies ~$125M per quarter if fully realized from Q1. Combined with the $40/ton net pricing improvement (ASP +$60, cost +$20) on ~4.1M tons, that's another ~$164M. But these overlap — the slab benefit IS part of the ASP improvement (redirecting low-value slab tons to higher-value products). Net incremental EBITDA vs Q4 2025 (-$21M) comes from: slab contract end (~$125M), pricing improvement net of cost (~$80M non-slab), footprint savings (~$25M/quarter from Steelton etc.). That totals ~$230M incremental, putting Q1 at ~$210M — right at the threshold. The question is whether all these improvements land cleanly in Q1 or phase in over H1. Coin-flip territory with slight lean below.
Management guided Q1 ASP up $60/ton and costs up $20/ton, implying $40/ton net improvement. On 4M+ tons, that alone generates ~$160M improvement from Q4's -$21M baseline. Add the slab contract benefit (even partial realization of $500M annualized = $80-125M/quarter) and footprint savings. The math suggests $200M is achievable if HRC pricing holds. Current tariff environment (25% Section 232 + 50% pig iron) supports pricing. Volume guidance of 16.5-17M tons annually implies ~4.1M/quarter. Slight lean YES based on the arithmetic, tempered by execution risk on the first transition quarter.
I'm skeptical of Q1 hitting $200M because transition quarters typically underperform the steady-state benefit. The slab contract ended Dec 2025, but redirecting 1.5M annual tons (375K/quarter) to higher-margin products requires operational ramp — new customer qualifications, product mix adjustments, and capacity reallocation. Q1 seasonality in steel is also typically weaker (winter impact on construction, auto production seasonality). The CEO's $37M stock sale at $12.42 immediately after guidance — followed by stock declining to $8.40 — suggests management may have known Q1 would disappoint relative to the bullish narrative. I'd expect $130-170M, just below the $200M threshold.
The consensus analyst estimates are relevant context — 12 analysts have an average Hold rating. If $200M+ EBITDA were widely expected, the stock at $8.40 (0.4x sales) would likely be higher. The market appears to doubt the magnitude or timing of the inflection. The slab contract benefit is the one element that's mechanistic (contract ends, cost goes away), but converting those tons to higher-value products involves execution. HRC pricing environment is supportive but uncertain. Net assessment: the components are there for $200M but the probability of all executing cleanly in Q1 is below 50%.
Slab contract expiration provides ~$125M/quarter benefit. Q1 ASP up $60/ton with cost up $20/ton helps. But $200M is a high bar for a transition quarter. FY2025 was $37M total. Getting to $200M in one quarter requires perfect execution. More likely $120-180M range. Below 50% probability.
The arithmetic supports $200M if you combine slab benefit, pricing improvement, and cost savings. But Q1 is a transition quarter with execution risk. 50:1 operating leverage cuts both ways — small shortfalls in pricing or volume significantly impact EBITDA. Near coin-flip with slight lean NO.
Three catalysts (slab end, pricing, cost savings) converge in Q1 but timing uncertainty is high. CEO stock sale is a negative signal on Q1 expectations. HRC pricing must hold above $800/ton. Lean NO but within uncertainty bounds of YES.
Resolution Criteria
Resolves YES if CLF reports Q1 2026 adjusted EBITDA (as defined by CLF's standard non-GAAP reconciliation) of $200M or above. Resolves NO if adjusted EBITDA is below $200M or if CLF does not report Q1 2026 results by the resolution date.
Resolution Source
CLF Q1 2026 earnings release and 10-Q filing
Source Trigger
Q1 2026 EBITDA — first quarter reflecting slab contract benefit; the make-or-break data point
Full multi-lens equity analysis